🔎 Trials Near Me

Home › Asthma › Ohio

Pag-aaral pangklinika para sa Asthma sa Ohio

14 pag-aaral para sa Asthma ang naghahanap ng mga kalahok sa mga site sa Ohio.

Mga Lungsod sa Ohio

Opisyal na teksto ng pag-aaral (English)

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

  • Research Site, Toledo
Nagre-recruitPhase 2
Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06932263

Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

  • Research Site, Cleveland
Nagre-recruitPhase 3
Edad 6 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07444567

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

  • Research Site 11, Dayton
Nagre-recruitPhase 3
Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07359846

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

  • Toledo Institute of Clinical Research Inc., Toledo
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06977581

A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma

  • Research Site, Cincinnati
  • Research Site, Cleveland
  • Research Site, Toledo
Nagre-recruitPhase 3
Edad 5 hanggang 11 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT06023589

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  • GSK Investigational Site, Cincinnati
  • GSK Investigational Site, Cleveland
Nagre-recruitPhase 3
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT05757102

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

  • Research Site, Cincinnati
Nagre-recruitPhase 2
Edad 4 hanggang 11 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07525375

Registry of Asthma Characterization and Recruitment 3 (RACR3)

  • Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT05272241

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  • Research Site, Cincinnati
  • Research Site, Columbus
  • Research Site, Columbus
  • at 3 pa
Nagre-recruitPhase 3
Edad 12 hanggang 17 · Lahat ng kasarian · Na-update Ago 13, 2026 · NCT06307665

SMART@Home Feasibility Trial

  • Cincinnati Children's Hospital Medical Center, Cincinnati
Nagre-recruit
Edad 12 hanggang 18 · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT06159127

Protocol CAUSE-03 / CHEETAH

  • Cincinnati Children's Hospital Medical Center: Asthma Center, Cincinnati
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Hul 1, 2026 · NCT06136091

Humidity Asthma Interventions for Low Socioeconomic Status Children

  • Case Western Reserve University, Cleveland
  • Cleveland Clinic, Cleveland
Nagre-recruit
Hanggang edad 18 · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT07453667

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

  • Toledo Institute of Clinical Research Inc, Toledo
Nagre-recruitObservasyonal na pag-aaral
Edad 5 hanggang 100 · Lahat ng kasarian · Na-update Hun 2, 2026 · NCT07228026

45th Multicenter Airway Research Collaboration

  • MetroHealth, Cleveland
Nagre-recruitPhase 4
Edad 18 hanggang 54 · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT07166939

Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.